title: Abeta modulation: the next generation of AD therapeutics.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492-7660, USA. kevin.felsenstein@bms.com
authors.forename: K M
authors.initials: KM
authors.lastname: Felsenstein
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000187:drug effects / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D015195:Drug Design; D006801:Humans; D011499:Protein Processing, Post-Translational
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor